Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease.
Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease.
复制标题
对1000个遗传性视网膜疾病的连续家庭进行临床焦点分子研究。
DOI:
10.1016/j.ophtha.2017.04.008
复制
发表时间:
2017-09
期刊:
影响因子:
13.7
通讯作者:
Tucker BA
中科院分区:
文献类型:
--
作者:
Stone EM;Andorf JL;Whitmore SS;DeLuca AP;Giacalone JC;Streb LM;Braun TA;Mullins RF;Scheetz TE;Sheffield VC;Tucker BA
To devise a comprehensive multi-platform genetic testing strategy for inherited retinal disease and describe its performance in 1,000 consecutive families seen by a single clinician. The clinical records of all patients seen by a single retina specialist between January 2010 and June 2016 were reviewed and all patients who met the clinical criteria for a diagnosis of inherited retinal disease were included in the study. Each patient was assigned to one of 62 diagnostic categories and this clinical diagnosis was used to define the scope and order of the molecular investigations that were performed. The number of nucleotides evaluated in a given subject ranged from two (a multiplex allele-specific assay for the most common mutations in BBS1 and BBS10) to nearly 900,000 (the coding sequences, and splice junctions of 305 genes known to cause inherited retinal disease). Disease-causing genotypes were identified in 760 families (76%). These genotypes were distributed across 104 different genes. More than 70% of these 104 genes have coding sequences small enough to be efficiently packaged into an adeno-associated virus. Mutations in ABCA4 were the most common cause of disease in this cohort (173 families) while mutations in 80 genes caused disease in five or fewer families (i.e., 0.5% or less). Disease-causing genotypes were identified in 576 of the families without next generation sequencing (NGS). This included 23 families with mutations in the repetitive region of RPGR exon 15 that would have been missed by NGS. Whole exome sequencing of the remaining 424 families revealed mutations in an additional 182, and whole genome sequencing of four of the remaining 242 families revealed two additional genotypes that were invisible by the other methods. Performing the testing in a clinically-focused tiered fashion would be 6.1% more sensitive, 17.7% less expensive and have a significantly lower average false genotype rate than using whole exome sequencing to assess more than 300 genes in all patients (7.1 vs. 128%; p<0.001). Genetic testing for inherited retinal disease is now more than 75% sensitive. A clinically-directed tiered testing strategy can increase sensitivity and improve statistical significance without increasing cost.
登录
查看更多内容
影响因子:
3.5
作者:
Braun TA;Mullins RF;Wagner AH;Andorf JL;Johnston RM;Bakall BB;Deluca AP;Fishman GA;Lam BL;Weleber RG;Cideciyan AV;Jacobson SG;Sheffield VC;Tucker BA;Stone EM
通讯作者:
Stone EM
影响因子:
4.6
作者:
Kansakoski, Johanna;Jaaskelainen, Jarmo;Raivio, Taneli
通讯作者:
Raivio, Taneli
影响因子:
56.9
作者:
KAJIWARA, K;BERSON, EL;DRYJA, TP
通讯作者:
DRYJA, TP
影响因子:
30.8
作者:
通讯作者:
--
DOI:
10.1126/science.1232033
发表时间:
2013-02-15
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Mali P;Yang L;Esvelt KM;Aach J;Guell M;DiCarlo JE;Norville JE;Church GM
通讯作者:
Church GM